Advice Pool
#1 in Business Subscribe Email Print

You are here: Home > Business > Careers Employment > Playing from the Blue Tees: Women in the Federal Government

Tags

  • pharmaceutical
  • management
  • leadership
  • biological product

  • Links

  • Spanish Resorts - Benidorm and The Costa Blanca
  • Another Side to Oregon Tourism
  • Patent Writing India - The Patent Amendment Act, 2002
  • Advice Pool - Playing from the Blue Tees: Women in the Federal Government

    Throughout the past decade, workplace diversity issues have allowed organizations to adjust their policies in response to the need for workplace
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    equality in all aspects. As a result of the dynamic political, social and economic changes, some companies have willingly become more inclusive
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    integrating women, people of color, gays/lesbians, and individuals with disabilities into their workforce at all levels of their organizations.
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    However, others have failed to make this paradigm shift. The Federal government has failed to see the benefits of a diverse workforce, which is
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    evident by the lack of diversity of the people it serves. Research by the Center for Creative Leadership (2002), show women in business have be
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    n required to adapt to a well established hierarchal system built around the strengths of its majority of male players. As women have entered th
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    workplace, they initially try to create only a modest variant in a male dominated workplace. Gender diversity could be very beneficial to the
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Federal government, causing greater creativity in group decision-making and improved task performance.

    Leadership is usually considered to be p
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    edominantly a male prerogative in corporate, political, military, and other sectors of our society. This might explain why, although women have
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ained increased access to supervisory and middle management positions, they remain underrepresented in leadership positions. Throughout history
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    women have been contributors to society, helped shaped America, and exercised their power and their abilities through various interests. But t
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    e recognition as leaders is still slow to come.

    Women are still confronted by an invisible barrier preventing their rise into leadership ranks
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    he “glass ceiling.” However, studies indicate that women are inching through the glass ceiling that has prevented them from attaining leadershi
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    positions. When we look at the surveys and research, women seem to have progressed in the last couple of years in terms of management positions
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    . The caveat however is, women who achieve these positions are usually placed under closer scrutiny and their evaluation is not always positive
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    While studies propose that women are likely to receive positive evaluations when their leadership roles are defined in feminine terms, on tradi
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ional, masculine measures of leadership, women’s leadership is often perceived to be lower than their male counterparts.

    Some women have develo
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ed strategies for overcoming workplace barriers to career advancement and achieved senior positions. While these barriers do not restrict the ca
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    eers of all women that they impact, a significant number is evident from the poor representation of women at senior levels. The limited number o
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    women reaching the highest positions in the government indicates that further attention to overcoming these barriers in the future is necessary


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.advicepool.org.ua/article/12920/advicepool-Playing-from-the-Blue-Tees-Women-in-the--Federal-Government.html">Playing from the Blue Tees: Women in the Federal Government</a>

    BB link (for phorums):
    [url=http://www.advicepool.org.ua/article/12920/advicepool-Playing-from-the-Blue-Tees-Women-in-the--Federal-Government.html]Playing from the Blue Tees: Women in the Federal Government[/url]

    Related Articles:

    Canadian Store Fixtures

    Phone words - Top 5 Tips to Help Maximise Advertising Spending

    Preparing For A Job Interview - Questions You May Be Asked

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com